What are the classification rules according to EU Regulation 2017/745?

 

According to Annex VIII of the new EU Regulation 2017/745, the classification of medical devices is based on the intended use and the worst-case rule (the highest applies between the multiple applicable classes; the most critical of the multiple intended uses applies).

 

  • Substance-based DM: non-invasive consisting of a substance or mixture of substances, intended for in vitro use, fall into class III.
  • Invasive DMs: they fall into class I if their duration of use is temporary; in-class IIA if the duration is short-term; in-class IIB if long-term.
  • Invasive surgical DM: for short and medium-term use they fall into class IIA; if absorbed or administering medicinal products are in class IIB; if related to the heart, they fall into class III.
  • Class III also includes breast and ear implants, surgical nets, disc prostheses, and active implants.
  • Medical software: class IIA if the software provides information useful for making decisions for diagnostic or therapeutic purposes; if the information could cause the patient's death, the software is in class III; if the information could deteriorate the health conditions, it falls into class IIB; otherwise the software is class I.
  • DM with ancillary medicine: class III
  • Absorbed or locally dispersed DM: they fall into class III if absorbed systemically to achieve their intended use if they achieve their intended use in the gastrointestinal tract; in-class IIA if applied to the skin, in the nasal or oral cavity; otherwise in class IIB.

 

I3CGLOBAL is a leading company providing expert support and advice in Regulatory compliance to pharmaceutical, chemical, and medical device companies.

Comments

Popular posts from this blog

Understanding FDA Registration and Certification for Food Facilities

EC REP: European Authorized Representative.

MHRA UK Responsible Person Services By I3CGLOBAL CompanY